1255639-56-5
1255639-56-5
Chemical Structure
Estriol-13C3
Synonym(s): Oestriol-13C3
- CAS No.: 1255639-56-5
- Formula:C1513C3H24O3
- Molecular Weight:291.36
IUPAC Name: (8R,9S,13S,14S,16R,17R)-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[i]phenanthrene-3,16,17-triol-2,3,4-13C3
InChIKey: PROQIPRRNZUXQM-FDFADMNFSA-N
SMILES: C[C@@]12[C@](C[C@H]([C@@H]2O)O)([H])[C@@]3([H])[C@@](CC1)([H])C4=C[13CH]=[13C](O)[13CH]=C4CC3
Biological Activity: Estriol-13C3 is the 13C-labeled Estriol. Estriol is an antagonist of the G-protein coupled estrogen receptor in estrogen receptor-negative breast cancer cells.
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Estriol-13C3 | Estriol-13C3 is the 13C-labeled Estriol. Estriol is an antagonist of the G-protein coupled estrogen receptor in estrogen receptor-negative breast cancer cells. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Estriol (Standard) | 99.59% | Estriol (Standard) is the analytical standard of Estriol. This product is intended for research and analytical applications. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Estriol-d | Estriol-d is the deuterium labeled Estriol. Estriol is an antagonist of the G-protein coupled estrogen receptor in estrogen receptor-negative breast cancer cells. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Estriol-d2 | 98.47% | Estriol-d2 is the deuterium labeled Estriol. Estriol is an antagonist of the G-protein coupled estrogen receptor in estrogen receptor-negative breast cancer cells. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Estriol-d3-1 | Estriol-d3-1 is the deuterium labeled Estriol. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Estriol-d3 | 99.62% | Estriol-d3 is the deuterium labeled Estriol. Estriol is an antagonist of the G-protein coupled estrogen receptor in estrogen receptor-negative breast cancer cells. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Estriol | 98.05% | Estriol (Oestriol), an orally active estrogen, is a ERα and ERβ agonist. Estriol is a potent GPR30 antagonist in estrogen receptor-negative breast cancer cells. Estriol can ameliorate disease severity through immunomodulatory mechanisms that decrease tissue inflammation. Estriol has powerful proconvulsant effects. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
